News

27 clinical studies in pancreatic cancer are on our radar August 18, 2021 We have received 27 applications to our call for projects in pancreatic and biliary tract cancer, announced earlier this year. This Request for Application (RFA) is a joint initiative by the Anticancer Fund and the Rising Tide Foundation for Clinical Cancer Research, a Swiss non-profit organisation. …

27 clinical studies in pancreatic cancer are on our radar Read More »

Setting the Groundwork for Patient-Centric 1st in Human Clinical Trial Funding Opportunities August 11, 2021 Rising Tide Foundation for Clinical Cancer Research operates with the goal of helping patients improve their quality of life and win the fight against cancer. In 2017, Melanoma Research Alliance and RTFCCR joined forces to fund a European-led Team Science Award (TSA). In 2019, the …

Setting the Groundwork for Patient-Centric 1st in Human Clinical Trial Funding Opportunities Read More »

Managing Symptoms for Patients: A Call to Study Supportive Care July 28, 2021 We are proud to share this interview touching on one of our focus areas – symptom management. Kudos to our collaboration partners ASCO and Conquer Cancer. Interview with Dr. Lage – by Jennifer Temel, MD More about the collaboration between the Rising …

Managing Symptoms for Patients: A Call to Study Supportive Care Read More »

RTFCCR and Patvocates collaborate to enhance patient engagement in cancer research projects July 7, 2022 Over the past two years, the Rising Tide Foundation for Clinical Cancer Research, a philanthropic funder of clinical cancer research, partnered with Patvocates to identify gaps in patient engagement in cancer research projects. The goal was to understand how funding institutions can encourage …

RTFCCR and Patvocates collaborate to enhance patient engagement in cancer research projects Read More »

TRIAL UPDATE: First patient was enrolled in the EORTC 1945 July 1, 2021 OligoRARE trial in oligometastatic rare cancers OligoRARE is an international study with 6 participating countries in Europe and a collaboration with the British Columbia Cancer Agency in Canada.  EORTC would like to thank The Anticancer Fund and Rising Tide Group for supporting …

TRIAL UPDATE: First patient was enrolled in the EORTC 1945 Read More »